Enzootic Overview
Enzootic is an animal biotechnology and genetics company positioned to vertically support breeding and farming of all-female freshwater and marine shrimp. Farming monosex populations of shrimp offers enhancement in performance and economic value. In the absence of the dominant, more-aggressive males, all-female populations are well suited to intensive farming, demonstrating uniform growth, higher survival rates, and superior feed conversion ratios. With these advantages in mind, Enzootic has developed a cell transplantation technology that is used for the commercial production of all-female shrimp populations, without the use of hormones, chemicals, or genetic modifications. The company's technology taps into the natural sex differentiation mechanism of crustaceans and harnesses their unique sexual plasticity to realize the goal of all-female aquaculture.
Cumulative Funding Raised Over Time ($)
$1.0M
$2.5MJan 2015
Latest News
growth-positive
'Super shrimp' may prevent a disease that affects millions
Ben-Gurion University researchers have developed a monosex prawn that produces only female offspring, which could increase aquaculture yields and help prevent the spread of water-bound parasites. The prawns were developed in collaboration with Enzootic, an Israeli company specializing in all-female monosex aquaculture biotechnologies. The development of these prawns could have a positive impact on the companys growth. The key themes of the article are the development of monosex prawns and their potential benefits in poverty alleviation, environmental protection, and disease reduction. The structured issues discussed in the article include customers and partners. The article does not mention any specific customers, investors, acquisition or investment amounts, layoffs, or valuation amount. The event described in the article does not have a specific date mentioned. My confidence in this answer is 8/10.
CustomersPartners
growth-positive
NRGene: New High-Quality Shrimp Genome Assembly May Reveal Why Females are Superior
Enzootic, an animal biotechnology and genetics company, has partnered with NRGene to complete the sequencing and assembly of the worlds first high-quality genome of freshwater shrimp. The genome study aims to understand the performance advantages of farming all-female populations of shrimp. The partnership with NRGene will enhance the breeding of all-female broodstock. The genome assembly is expected to have a positive impact on shrimp production and promote more effective and sustainable shrimp farming practices. Enzootic is a company focused on breeding and farming all-female freshwater and marine shrimp, while NRGene is a provider of genomic big data analysis.
Partners
growth-positive
BGU Spin-off Enzootic Wins Best Company at AgriVest
Enzootic Ltd. has won the best AgTech company competition at the AgriVest meeting. The conference showcased innovative start-ups in agricultural technology, with Enzootic being recognized for their platform in crustacean aquaculture. The event brought together investors, agriculture companies, and government representatives from around the world. Enzootics vision is to introduce advancements in life science research into crustacean aquaculture and ecological bio-control. The conference is organized by Trendlines Agtech, Invest in Israel, and GreenSoil Investments. The CEO of Trendlines Agtech highlighted the potential of investing in innovative developments in the agricultural industry.
PartnersInvestment
growth-positive
Start-up finds 'holy grail' in female prawns, shrimp
US-Israeli start-up Enzootic has developed a technology to produce commercially available all-female populations of giant river prawns without the use of chemicals, hormones, or genetic engineering. This technology can be applied to any crustacean. Enzootics method involves using a single injection of parental cells to produce females with WW chromosomes, which are then crossed with normal males to produce all-female offspring. The crustacean aquaculture market is growing rapidly, and Enzootic aims to increase revenues and attract new customers with its technology. The company recently won a start-up competition at the International AgriVest Conference.
Customers
| Sector | Agriculture & Food Technologies |
Funding
| Total funding | $2.5M |
| Last funding | $1.5M |
| Stage | Mature |
| Rounds | 2 |
| Investors | 0 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | enzootic.com |
Locations
Eliyahu Nawi Street 40, Beer-Sheva, Israel
33 Canton Road, Tsim Sha Tsui, Kowloon, Hong Kong
Photos & Videos
2 item(s)
Enzootic Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Agriculture & Food TechnologiesAg TechGenetics & InputTarget Customer
Agriculture & FoodMarine LifeSea FoodCore Technology
BiologicalsCellsTags (10)
biotechnologynon-gmoagtechlivestockfish-farmsaquaculturegeneticssmart-farmingbreedingveterinaryGeographic Markets
AsiaEnzootic Financials
$2.5M
Total funding
Undisclosed
Capital raised
$1.5M
Last funding
Mature
Funding stage
2
Total rounds
0
Investors
Cumulative Funding Raised Over Time ($)
$1.0M
$2.5MJan 2015
Private Equity Funding
Seed
Jan 2015
$1.5M
Undisclosed Round
$1M
Enzootic Lifecycle
Cumulative Funding Raised Over Time
$1.0M
$2.5MJan 2015
All Events
Seed
Jan 2015
$1.5M
Undisclosed Round
$1M
Enzootic News
4 articles
growth-positive
'Super shrimp' may prevent a disease that affects millions
Ben-Gurion University researchers have developed a monosex prawn that produces only female offspring, which could increase aquaculture yields and help prevent the spread of water-bound parasites. The prawns were developed in collaboration with Enzootic, an Israeli company specializing in all-female monosex aquaculture biotechnologies. The development of these prawns could have a positive impact on the companys growth. The key themes of the article are the development of monosex prawns and their potential benefits in poverty alleviation, environmental protection, and disease reduction. The structured issues discussed in the article include customers and partners. The article does not mention any specific customers, investors, acquisition or investment amounts, layoffs, or valuation amount. The event described in the article does not have a specific date mentioned. My confidence in this answer is 8/10.
CustomersPartners
growth-positive
NRGene: New High-Quality Shrimp Genome Assembly May Reveal Why Females are Superior
Enzootic, an animal biotechnology and genetics company, has partnered with NRGene to complete the sequencing and assembly of the worlds first high-quality genome of freshwater shrimp. The genome study aims to understand the performance advantages of farming all-female populations of shrimp. The partnership with NRGene will enhance the breeding of all-female broodstock. The genome assembly is expected to have a positive impact on shrimp production and promote more effective and sustainable shrimp farming practices. Enzootic is a company focused on breeding and farming all-female freshwater and marine shrimp, while NRGene is a provider of genomic big data analysis.
Partners
growth-positive
BGU Spin-off Enzootic Wins Best Company at AgriVest
Enzootic Ltd. has won the best AgTech company competition at the AgriVest meeting. The conference showcased innovative start-ups in agricultural technology, with Enzootic being recognized for their platform in crustacean aquaculture. The event brought together investors, agriculture companies, and government representatives from around the world. Enzootics vision is to introduce advancements in life science research into crustacean aquaculture and ecological bio-control. The conference is organized by Trendlines Agtech, Invest in Israel, and GreenSoil Investments. The CEO of Trendlines Agtech highlighted the potential of investing in innovative developments in the agricultural industry.
PartnersInvestment
growth-positive
Start-up finds 'holy grail' in female prawns, shrimp
US-Israeli start-up Enzootic has developed a technology to produce commercially available all-female populations of giant river prawns without the use of chemicals, hormones, or genetic engineering. This technology can be applied to any crustacean. Enzootics method involves using a single injection of parental cells to produce females with WW chromosomes, which are then crossed with normal males to produce all-female offspring. The crustacean aquaculture market is growing rapidly, and Enzootic aims to increase revenues and attract new customers with its technology. The company recently won a start-up competition at the International AgriVest Conference.
Customers
Enzootic Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 32 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
Enzootic Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 101/100 |
| Missing | markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 514824259 |
| Crunchbase | enzootic |
| Phone | +97288584958 |
| Last updater | Asaph Wagner |
| Updater email | asaphwagner@hotmail.com |
| Last update | 2020-07-27T00:00:00.000Z |
| Created | 2015-01-15T00:00:00.000Z |
| Claimed | Yes |